von Wichert P, Boes J
Med Klin. 1979 Oct 19;74(42):1544-7.
Effects of the beta 2-receptor stimulating drug fenoterol were investigated after administration of beta-receptor blocking agents in 12 patients with obstructive respiratory disease and a hyperreactive bronchial system (positive acetylcholine test). In a double blind trial pindolol (universal beta-receptor blocking drug) and metoprolol (a cardioselective substance) were compared after administration of equally effective doses of 5 and 100 mg respectively. Whole-body plethysmography showed that both beta-receptor blocking drugs caused no bronchial constriction; the bronchodilating effects of fenoterol were not reduced. These findings must cast doubt on the differentiation between cardioselective and non-cardioselective beta-receptor blocking agents as far as practical therapeutic implications are concerned.
在12例患有阻塞性呼吸系统疾病且支气管系统反应性过高(乙酰胆碱试验呈阳性)的患者中,研究了β受体阻滞剂给药后β₂受体激动剂非诺特罗的效应。在一项双盲试验中,分别给予5毫克和100毫克等效剂量的吲哚洛尔(通用β受体阻滞剂)和美托洛尔(一种心脏选择性药物)后进行比较。全身体积描记法显示,两种β受体阻滞剂均未引起支气管收缩;非诺特罗的支气管扩张作用未减弱。就实际治疗意义而言,这些发现必然使人对心脏选择性和非心脏选择性β受体阻滞剂之间的区分产生怀疑。